Στροφείς (rotors) και πραγματικότητα. Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ»

Similar documents
Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Catheter Ablation for Persistent Atrial Fibrillation

«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

PVI and What Else for Persistent AF Lessons Learned from STAR AF 2 CCCEP 2015 October 31, New York

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Creating Order out of Chaos: New Research into Treatment of Atrial Fibrillation

ANALYSIS AND VISUALIZATION OF ATRIAL FIBRILLATION ELECTROGRAMS USING CROSS-CORRELATION

High density substrate mapping In AF

CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY

Outcomes of AF Ablation

Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we?

Debate-STAR AF 2 study. PVI is not enough

CARDIOLOGY GRAND ROUNDS

Χρήση έξυπνων τεχνολογιών στην ανίχνευση κολπικής μαρμαρυγής Use of smart technology in atrial fibrillation detection

Long Standing Persistent AF ; CPVI is enough for it

Surgical Ablation for Lone AF: What have we learned after 30 years?

A Dynamic model of Pulmonary Vein Electrophysiology. Harry Green 2 nd year Ph.D. student University of Exeter

atrial fibrillation, catheter ablation, driver, mapping, rotor

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

Role of LAA isolation in AF cure

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

Accepted Manuscript. What Can We Learn From a Novel Global Positioning System in Persistent Atrial Fibrillation? Kenton Zehr, M.D.

Rotor Mapping A FIRM Foundation Exists

CARDIOINSIGHT NONINVASIVE 3D MAPPING SYSTEM VALUE ACROSS THE CARE CONTINUUM

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

480 April 2004 PACE, Vol. 27

Spatio-temporal Dispersion: Mechanistic Significance

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

Diagnostic Electrophysiology & Ablation

Catheter ablation of AF Where do we stand, where do we go?

Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary

Ablation Lesion Assessment

Case Report Electroanatomical Mapping and Ablation of Upper Loop Reentry Atrial Flutter

Ablation of persistent AF Is it different than paroxysmal?

Cardiac Arrhythmia Mapping!

Mechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm

New Tools to Treat AF in CHF Patients. Disclosures

The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

CATHETER ABLATION FOR ATRIAL FIBRILLATION WHEN and HOW

VISITAG SURPOINT. OPEN AND ENROLLING: Please Refer Patients! MHIF FEATURED STUDY: SPONSOR: Biosense Webster. PI: Daniel Melby, MD

Peri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus

The Regional Distribution and Correlation. Complex Fractionated Atrial Electrograms and Dominant Frequency in. during Atrial Fibrillation

Individualised strategy approach to AF ablation

Interventional solutions for atrial fibrillation in patients with heart failure

What s new in my specialty?

A New Approach for Catheter Ablation of Atrial Fibrillation: Mapping of the Electrophysiologic Substrate

FA et Apnée du Sommeil

Atrial Fibrillation Ablation: in Whom and How

How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Should hybrid ablation be the standard of care instead of transcatheter ablation techniques?

Electrophysiology 101: What Do Surgeons Need to Know. Richard B Schuessler PhD

LU:research Institutional Repository of Lund University

Queen s University, Kingston, Ontario, Canada. 2 London Health Sciences, London, Ontario, Canada.

Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis

Reentry in a Pulmonary Vein as a Possible Mechanism of Focal Atrial Fibrillation

Research Article Characterization of Electrograms from Multipolar Diagnostic Catheters during Atrial Fibrillation

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Case Report Simultaneous Accessory Pathway and AV Node Mechanical Block

Mapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria

Electrophysiologic Properties of Pulmonary Veins Assessed Using a Multielectrode Basket Catheter


Time to recurrence of atrial fibrillation influences outcome following catheter ablation

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ

Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation

Since pulmonary veins (PVs) have

FREQUENCY COHERENCE MAPPING OF CANINE ATRIAL FIBRILLATION: IMPLICATION FOR ANTI-ARRHYTHMIC DRUG-INDUCED TERMINATION

Ventricular Arrhythmias

Hunter, Ross J. For additional information about this publication click this link.

A request for a log book extension must be put in writing and sent to BHRS, Unit 6B, Essex House, Cromwell Business Park, Chipping Norton,

Mapping and Ablation in AF: how can we evaluate the lesion formation?

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

Atrial Fibrillation Ablation in Patients with Heart Failure

Long-Term ECG Monitoring Using an ILR. Evgeny Pokushalov, MD, PhD

Catheter Ablation of Atrial Tachycardia Originating from the Tip of Right Atrial Appendage

Πρώτης γραμμή θεραπεία η κατάλυση κοιλιακής ταχυκαρδίας στην ισχαιμική μυοκαρδιοπάθεια

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist

New Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Author s Accepted Manuscript

Declaration of conflict of interest NONE

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Catheter Ablation of Atrial Fibrillation

Characteristics of Rapid Rhythms Recorded Within Pulmonary Veins During Atrial Fibrillation

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013

The Future of Catheter Ablation

Principles and Applications of Electrical Circuits and Signal Theories in EP

Case Report. Sumito Narita MD 1;3, Takeshi Tsuchiya MD, PhD 1, Hiroya Ushinohama MD, PhD 2, Shin-ichi Ando MD, PhD 3

Recent observations have focused attention on the PVs as a source of ectopic activity i determining i AF

Evidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins

Use of Catheter Ablation in the Treatment of Ventricular Tachycardia Triggered by Premature Ventricular Contraction

Jesus M. Paylos, C. Ferrero, L. Azcona, A. Morales, M. A. Vargas, L. Lacal, V. Gomez Tello.

Mechanisms of atrial fibrillation terminations in humans: insights from non-invasive cardiac mapping

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Case 1 Left Atrial Tachycardia

Transcription:

Στροφείς (rotors) και πραγματικότητα. Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ»

Mechanisms that sustain Atrial Fibrillation multiwavelet hypothesis, since 1964 a critical number of wavelets, which travel throughout the atria, colliding, combining or dividing and generating new wavelets that perpetuate the process.

What is a Rotor? 1990 localized sources generating wavefronts spiral wave conduction velocity, depends on wavefront curvature unexcited but excitable tissue no fixed wavelength in rotor generated spiral waves.

Phase Mapping of Rotors and Singularities phase mappi g tech ique by Gray et a, i 1998 tracki g of the spira a d its tip dy amics, i space, over time. Each co or represe ts a phase i the excitatio recovery cyc e, a d a PS is defi ed as a site here a of the phases co verge Circ Res. 2013;112:849-862

Spatiotemporal stability meandering around a relatively fixed core rotors may drift over larger distances. Cardiovascular Research (2016) 109, 480 492

Dominant frequency a sma umber of high-freque cy rotors i the LA mai tai the overa activity Circ Res. 2013;112:849-862

(82.4% (FIRM-guided) vs 44.9% (FIRM-blinded) free of AF after median 273 days J Am Coll Cardiol 2012;60: 628 36)

freedom from AF was higher for FIRM-guided than conventional therapy (77.8% vs. 38.5% at 890 days) J Am Coll Cardiol 2014;63:1761 8

Single procedure success rate after mean 18 months of followup was 30% free from documented AF recurrence and 21% free from atrial tachyarrhythmias Heart Rhythm 2016;13:636 641

FIRM-identified rotor sites do not exhibit distinctive electrophysiological characteristics with regard to dominant frequency or Shannon entropy; rotational activation (>1 rotation) on electroanatomic mapping was not observed at FIRM-identified rotor sites Benharash et al, Circ Arrhythm Electrophysiol. 2015;8:554-561

12 months of follow-up, the primary end point of freedom from any recurrent AF/AT without antiarrhythmic drugs 14% of patients with FIRM-only, 52% with FIRM plus PVI, 76% with standard PVI plus posterior wall (PW) and non-pv trigger ablation Increased procedure and radiofrequency times J Am Coll Cardiol 2016;68:274 82)

reasons for FIRM ablation discrepancy ablation success rates ranging from as high as 82% to as low as 21% selected population (a different prevalence of nonparoxysmal AF) statistical variation due to the small sample size learning curve effect The detection of rotors may be limited by the electrode density of the Constellation basket catheter.

Different nets catch different fishes Simultaneous electrode-tissue contact with a basket catheter is often less than satisfactory at some, if not most, of the electrodes, limiting the fidelity of the data the interpolation algorithm is devised to demonstrate mainly rotational activity Cardiac motion may also exacerbate problems associated with interpolation.

the multipolar basket catheter provides inadequate coverage of the LA, with half the surface area unsampled, and decipherable atrial electrograms from only 48% of electrodes ablation of rotor sites, even when accompanied by PVI, did not result in AF termination in the majority (20/24; 83%) of patients. Benharash et al, Circ Arrhythm Electrophysiol. 2015;8:554-561

Differences Between Rotor Mapping Approaches rotor stability

Spatiotemporal stability How many rotations? What is the presice area of rotors activity? Different criteria lead to different results

Circulation, July 15, 2014 ECGI system with additional signal processing that included filtering, wavelet transform, and phase mapping and observed active AF sources the number of rotations detected by the ECGI system is much less than that detected by the FIRM approach, median 2.6 rotations a mean duration of 449 ± 89 ms 1 5 discrete regions in each patient. Driver ablation alone terminated 75% and 15% of persistent and long-lasting AF, The number of targeted driver regions increased with the duration of continuous AF

instability of rotors on the body surface and the strong effect of the HDF bandpass filtering on their stability increasing far-field effects on the electrical recordings. Percentage of time with rotors (top) and rotor duration (bottom) in surface phase maps from unfiltered and HDFfiltered surface potentials over a cohort of 14 AF patients Rodrigo et al, Heart Rhythm 2014;11:1584 1591.

Single wavefronts 36.6% ± 8.3% focal activations, 34.0% ± 8.6% disorganized activity, 23.7% ± 6.1% rotors, 3.3% ± 3.4% multiple wavefronts, 2.4% ± 3.9%. Pathik et al, Heart Rhythm 2017;-:1 11

technique 1 (activation/phase mapping, FIRM) vs technique 2 (unipolar electrograms/phase maps of activation) Revealed a source in 12 of 12 (100%) cases with spatial concordance in all cases and similar rotational characteristics Alhussseini et al, J Cardiovasc Electrophysiol, Vol. 28, pp. 615-622, June 2017

31 reports 2 full RCTs 29 reports were of nonrandomized or observational studies J Cardiovasc Electrophysiol. 2017;28:1371 1378.

ECVUE system 252 vest electrodes PVI +ROTORS ABL ± left atrial linear ablation seven regions 1.5 rotations in an area of < 2 cm² high rates of AF termination (64% of patients) and favourable outcomes at 1 year (78% freedom from AF recurrence). Europace (2017) 19, 1302 1309

a si g e-ce ter 1-group study, FIRM + PVI the media umber of rotors per patie t as 3.0 ider ra ge of e ectrodes as e as more f exib e catheter tip. single procedure, 13 (52%) patients were free of atrial tachyarrhythmia after a follow-up period of 13 ± 1 months J Cardiovasc Electrophysiol, Vol. 28, pp. 367-374, April 2017

The CARTOFINDER system CF software in combination with a basket catheter and a 3- dimensional mapping system Drivers with rotational activation were predominantly mapped to sites of low-voltage zones (81.8%). high reproducibility in finding the same RAP at different times J Am Coll Cardiol EP 2017

Ongoing trials Five randomized, prospective, controlled trials assign a total of >1,000 patients to either FIRM ablation or control.

CONCLUSIONS The concept of rapidly activating spiral rotors as a mechanism for AF-maintenance is still controversial. Lack of established criteria regarding to spatiotemporal stability of rotors Substantial heterogeneity exists among AF rotors mapping technologies large randomized trials with long-term follow-up are needed to determine the clinical impact of rotors elimination